Skip Navigation


Hum. Reprod. Advance Access originally published online on November 11, 2004
Human Reproduction 2005 20(1):226-230; doi:10.1093/humrep/deh590
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/1/226    most recent
deh590v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (39)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Greco, E.
Right arrow Articles by Tesarik, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greco, E.
Right arrow Articles by Tesarik, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction vol. 20 no. 1 © European Society of Human Reproduction and Embryology 2004; all rights reserved

Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa

Ermanno Greco1, Filomena Scarselli1, Marcello Iacobelli1, Laura Rienzi1, Filippo Ubaldi1, Susanna Ferrero1, Giorgio Franco1, Nazareno Anniballo1, Carmen Mendoza2,3 and Jan Tesarik2,4,5

1 Centre for Reproductive Medicine, European Hospital, Via Portuense 700, 00149 Rome, Italy, 2 MAR&Gen, Molecular Assisted Reproduction and Genetics, Gracia 36, 18002 Granada, 3 University of Granada, Campus Fuentenueva, 18004 Granada, Spain and 4 Laboratoire d'Eylau, 55 rue Saint-Didier, 75116 Paris, France

5 To whom correspondence should be addressed. Email: cmendoza{at}ugr.es

BACKGROUND: Sperm DNA damage (fragmentation) is a recently discovered cause of male infertility for which no efficient treatment has yet been found. Previous findings have suggested that clinically relevant sperm DNA damage may occur at the post-testicular level. This study was undertaken to assess the clinical usefulness of ICSI with testicular spermatozoa in this indication. METHODS: The percentage of spermatozoa with fragmented DNA, assessed by terminal deoxyribonucleotidyl transferase-mediated dUTP nick-end labelling assay, and ICSI outcomes were compared in two sequential attempts performed, respectively, with ejaculated and testicular spermatozoa in 18 men with increased sperm DNA fragmentation. RESULTS: The incidence of DNA fragmentation was markedly lower in testicular spermatozoa as compared with ejaculated spermatozoa. No differences in fertilization and cleavage rates and in embryo morphological grade were found between the ICSI attempts performed with ejaculated and with testicular spermatozoa. However, eight ongoing clinical pregnancies (four singleton and four twin) were achieved by ICSI with testicular spermatozoa (44.4% pregnancy rate; 20.7% implantation rate), whereas ICSI with ejaculated spermatozoa led to only one pregnancy which was spontaneously aborted. CONCLUSIONS: These data show that ICSI with testicular spermatozoa provides the first efficient assisted reproduction treatment option for men with high levels of sperm DNA damage.

Key words: DNA fragmentation/ejaculated spermatozoa/ICSI/sperm fertilizing ability/testicular spermatozoa


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
K. Tremellen
Oxidative stress and male infertility--a clinical perspective
Hum. Reprod. Update, May 1, 2008; 14(3): 243 - 258.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
S. E. M. Lewis and I. M. Agbaje
Using the alkaline comet assay in prognostic tests for male infertility and assisted reproductive technology outcomes
Mutagenesis, May 1, 2008; 23(3): 163 - 170.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. G. Alvarez and S. Lewis
Sperm chromatin structure assay parameters measured after density gradient centrifugation are not predictive of the outcome of ART
Hum. Reprod., May 1, 2008; 23(5): 1235 - 1236.
[Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. Fernandez-Gonzalez, P. N. Moreira, M. Perez-Crespo, M. Sanchez-Martin, M. A. Ramirez, E. Pericuesta, A. Bilbao, P. Bermejo-Alvarez, J. d. D. Hourcade, F. R. d. Fonseca, et al.
Long-Term Effects of Mouse Intracytoplasmic Sperm Injection with DNA-Fragmented Sperm on Health and Behavior of Adult Offspring
Biol Reprod, April 1, 2008; 78(4): 761 - 772.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Ciriminna, M.L. Papale, P.G. Artini, M. Costa, L. De Santis, L. Gandini, L. Parmegiani, G. Ragni, A. Revelli, L. Rienzi, et al.
Impact of Italian legislation regulating assisted reproduction techniques on ICSI outcomes in severe male factor infertility: a multicentric survey
Hum. Reprod., September 1, 2007; 22(9): 2481 - 2487.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
I.M.W. Ebisch, C.M.G. Thomas, W.H.M. Peters, D.D.M. Braat, and R.P.M. Steegers-Theunissen
The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility
Hum. Reprod. Update, March 1, 2007; 13(2): 163 - 174.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
R. Oliva
Protamines and male infertility
Hum. Reprod. Update, July 1, 2006; 12(4): 417 - 435.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. B. Boe-Hansen, J. Fedder, A. K. Ersboll, and P. Christensen
The sperm chromatin structure assay as a diagnostic tool in the human fertility clinic
Hum. Reprod., June 1, 2006; 21(6): 1576 - 1582.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. A. Makhlouf and C. Niederberger
DNA Integrity Tests in Clinical Practice: It Is Not a Simple Matter of Black and White (or Red and Green)
J Androl, May 1, 2006; 27(3): 316 - 323.
[Full Text] [PDF]


Home page
Hum ReprodHome page
L. Muriel, M. Meseguer, J. L. Fernandez, J. Alvarez, J. Remohi, A. Pellicer, and N. Garrido
Value of the sperm chromatin dispersion test in predicting pregnancy outcome in intrauterine insemination: a blind prospective study
Hum. Reprod., March 1, 2006; 21(3): 738 - 744.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Suganuma, R. Yanagimachi, and M. L. Meistrich
Decline in fertility of mouse sperm with abnormal chromatin during epididymal passage as revealed by ICSI
Hum. Reprod., November 1, 2005; 20(11): 3101 - 3108.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Greco, S. Romano, M. Iacobelli, S. Ferrero, E. Baroni, M. G. Minasi, F. Ubaldi, L. Rienzi, and J. Tesarik
ICSI in cases of sperm DNA damage: beneficial effect of oral antioxidant treatment
Hum. Reprod., September 1, 2005; 20(9): 2590 - 2594.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. G.Alvarez
The predictive value of sperm chromatin structure assay
Hum. Reprod., August 1, 2005; 20(8): 2365 - 2367.
[Full Text] [PDF]


Home page
Hum ReprodHome page
E. Greco, F. Scarselli, M. Iacobelli, L. Rienzi, F. Ubaldi, S. Ferrero, G. Franco, N. Anniballo, C. Mendoza, and J. Tesarik
Reply: 'Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa'
Hum. Reprod., July 1, 2005; 20(7): 2032 - 2033.
[Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
E. Seli and D. Sakkas
Spermatozoal nuclear determinants of reproductive outcome: implications for ART
Hum. Reprod. Update, July 1, 2005; 11(4): 337 - 349.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.